News & Events

Press Releases

Here's What's Going On at SI-BONE.


2018
Sep 20

SI-BONE Files Registration Statement for Proposed Initial Public Offering

SI-BONE Files Registration Statement for Proposed Initial Public Offering


Read more

Aug 7

SI-BONE, Inc. Announces 23 Commercial Health Insurance Plans Now “Exclusively” Cover Triangular iFuse Implant System® Based on Published Clinical Evidence

SI-BONE, Inc. Announces 23 Commercial Health Insurance Plans Now “Exclusively” Cover Triangular iFuse Implant System® Based on Published Clinical Evidence


Read more

Apr 9

SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular iFuse Implant System®

SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular iFuse Implant System®
Read more

Apr 9

SI-BONE, Inc. Hosts ISASS 2018 Sacroiliac Joint Workshop led by David Polly, MD, Bengt Sturesson, MD, Peter Whang, MD and Brad Duhon, MD

SI-BONE, Inc. Hosts ISASS 2018 Sacroiliac Joint Workshop led by David Polly, MD, Bengt Sturesson, MD, Peter Whang, MD and Brad Duhon, MD
Read more

Jan 2

SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion

SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Read more

2017
Oct 23

SI-BONE’s New iFuse-NavigationTM Set* and iFuse-3DTM Fenestrated SI Joint Fusion Implant to be Featured at the 2017 North American Spine Society Annual Meeting

SI-BONE’s New iFuse-NavigationTM Set* and iFuse-3DTM Fenestrated SI Joint Fusion Implant to be Featured at the 2017 North American Spine Society Annual Meeting
Read more

Oct 9

SI-BONE, Inc. Announces Utah’s Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure™ for Minimally Invasive SI Joint Fusion

SI-BONE, Inc. Announces Utah’s Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure™ for Minimally Invasive SI Joint Fusion
Read more

Sep 25

SI-BONE, Inc. Announces Publication of iMIA – a 2nd Multicenter Randomized Controlled Trial of the iFuse Implant System® vs Conservative Care

SI-BONE, Inc. Announces Publication of iMIA – a 2nd Multicenter Randomized Controlled Trial of the iFuse Implant System® vs Conservative Care
Read more

Aug 23

SI-BONE, Inc. Announces Highmark, Inc., 4th Largest Blue Cross Blue Shield Plan and 10th Largest U.S. Commercial Payor, Establishes Positive Coverage Policy for Minimally Invasive Sacroiliac Joint Fusion Exclusively for the iFuse Implant System®

SI-BONE, Inc. Announces Highmark, Inc., 4th Largest Blue Cross Blue Shield Plan and 10th Largest U.S. Commercial Payor, Establishes Positive Coverage Policy for Minimally Invasive Sacroiliac Joint Fusion Exclusively for the iFuse Implant System®
Read more

Aug 9

SI-BONE, Inc. Announces Publication of a Level I Study Demonstrating Strong Clinical Prediction for the Diagnosis of SI Joint Dysfunction

SI-BONE, Inc. Announces Publication of a Level I Study Demonstrating Strong Clinical Prediction for the Diagnosis of SI Joint Dysfunction
Read more

Aug 2

SI-BONE, Inc. Announces Minimally Invasive SI Joint Fusion using the iFuse Implant System® Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas

SI-BONE, Inc. Announces Minimally Invasive SI Joint Fusion using the iFuse Implant System® Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas
Read more

Jun 13

SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3DTM Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System®

SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3DTM Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System®
Read more

Jun 12

SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion

SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
Read more

May 8

SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion

SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
Read more

May 1

SI-BONE, Inc. Announces SI Joint Fusion Study Showed Patients Were 11X Less Likely to be Taking Opioids at Last Follow-Up Using the iFuse Implant

SI-BONE, Inc. Announces SI Joint Fusion Study Showed Patients Were 11X Less Likely to be Taking Opioids at Last Follow-Up Using the iFuse Implant
Read more

Apr 24

SI-BONE, Inc. Announces Publication of 6-year Clinical Results Demonstrating Long-Term Positive Outcomes of iFuse Implant System®

SI-BONE, Inc. Announces Publication of 6-year Clinical Results Demonstrating Long-Term Positive Outcomes of iFuse Implant System®
Read more

Apr 7

SI-BONE, Inc. Announces Published Guidance Recommendation for Minimally Invasive SI Joint Fusion from the National Institute for Health and Care Excellence (NICE)

SI-BONE, Inc. Announces Published Guidance Recommendation for Minimally Invasive SI Joint Fusion from the National Institute for Health and Care Excellence (NICE)
Read more

Apr 3

SI-BONE, Inc. Announces 50th Peer-Reviewed Publication for the iFuse Implant System® and 25,000th iFuse Procedure Performed Worldwide

SI-BONE, Inc. Announces 50th Peer-Reviewed Publication for the iFuse Implant System® and 25,000th iFuse Procedure Performed Worldwide
Read more

Mar 8

SI-BONE, Inc. Launches SI Joint Women's Health Initiative at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego, March 14 - 17

SI-BONE, Inc. Launches SI Joint Women's Health Initiative at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego, March 14 - 17
Read more

Jan 23

SI-BONE's iFuse Implant System® Requires Revision Surgery 5 Times Less Compared to SI Joint Fixation with Screws According to New Peer-Reviewed Clinical Publication

SI-BONE's iFuse Implant System® Requires Revision Surgery 5 Times Less Compared to SI Joint Fixation with Screws According to New Peer-Reviewed Clinical Publication
Read more

Jan 9

SI-BONE, Inc. Announces iFuse Implant System® Warranty Program in Support of Patients, Providers and Payors

SI-BONE, Inc. Announces iFuse Implant System® Warranty Program in Support of Patients, Providers and Payors
Read more

2016
Dec 15

Health Care Service Corporation (HCSC), the Fourth Largest Health Insurer in the United States, Establishes Exclusive Positive Coverage Policy for SI-BONE’s iFuse Implant System® for Minimally Invasive Sacroiliac Joint Fusion

Health Care Service Corporation (HCSC), the Fourth Largest Health Insurer in the United States, Establishes Exclusive Positive Coverage Policy for SI-BONE’s iFuse Implant System® for Minimally Invasive Sacroiliac Joint Fusion
Read more

Nov 2

CMS Publishes 2017 Final Hospital Outpatient and Ambulatory Surgical Center Payment Rule Increasing Outpatient Facility Reimbursement for MIS SI Joint Fusion Using SI-BONE's iFuse Implant System®

CMS Publishes 2017 Final Hospital Outpatient and Ambulatory Surgical Center Payment Rule Increasing Outpatient Facility Reimbursement for MIS SI Joint Fusion Using SI-BONE's iFuse Implant System®
Read more

Oct 27

SI-BONE, Inc. Announces SelectHealth of Utah to Cover Minimally Invasive Sacroiliac Joint Fusion Exclusively Using the iFuse Implant System® as the Only Proven Technology

SI-BONE, Inc. Announces SelectHealth of Utah to Cover Minimally Invasive Sacroiliac Joint Fusion Exclusively Using the iFuse Implant System® as the Only Proven Technology
Read more

Oct 5

SI-BONE, Inc. Continues Leadership in Clinical Evidence Transparency Initiative Adding INSITE 2-Year RCT Results to Yale University Open Data Access Program

SI-BONE, Inc. Continues Leadership in Clinical Evidence Transparency Initiative Adding INSITE 2-Year RCT Results to Yale University Open Data Access Program
Read more

Sep 28

Blue Cross Blue Shield of Nebraska Adopts Positive Coverage for Minimally Invasive Sacroiliac Joint Fusion

Blue Cross Blue Shield of Nebraska Adopts Positive Coverage for Minimally Invasive Sacroiliac Joint Fusion
Read more

Aug 24

SI-BONE, Inc. Announces Two-Year Results from a Randomized Controlled Trial of the iFuse Implant System® vs. Non-Surgical Management for Some Causes of Sacroiliac Joint Dysfunction

SI-BONE, Inc. Announces Two-Year Results from a Randomized Controlled Trial of the iFuse Implant System® vs. Non-Surgical Management for Some Causes of Sacroiliac Joint Dysfunction
Read more

Jul 18

SI-BONE, Inc. Announces 40th Peer-Reviewed Publication - a Multicenter Long Term Outcomes Study Showing Durable Results With the iFuse Implant System®

SI-BONE, Inc. Announces 40th Peer-Reviewed Publication - a Multicenter Long Term Outcomes Study Showing Durable Results With the iFuse Implant System®
Read more

Jul 5

SI-BONE, Inc. Appoints Tony Recupero Chief Commercial Officer

SI-BONE, Inc. Appoints Tony Recupero Chief Commercial Officer
Read more

Jun 20

SI-BONE, Inc. Closes $20 Million Round of Growth Financing Led by Arboretum Ventures

SI-BONE, Inc. Closes $20 Million Round of Growth Financing Led by Arboretum Ventures
Read more

Jun 16

SI-BONE, Inc. Announces Medicare Administrative Contractor First Coast Service Options, Inc. (FCSO) Establishes Coverage for MIS SI Joint Fusion

SI-BONE, Inc. Announces Medicare Administrative Contractor First Coast Service Options, Inc. (FCSO) Establishes Coverage for MIS SI Joint Fusion
Read more

Jun 15

Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System® for SI Joint Fusion

Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System® for SI Joint Fusion
Read more

Jun 13

iFuse is the Only SI Joint Fusion Implant with an FDA Cleared Indication citing clinical studies that demonstrated improvement in pain, patient function, and quality of life

iFuse is the Only SI Joint Fusion Implant with an FDA Cleared Indication citing clinical studies that demonstrated improvement in pain, patient function, and quality of life
Read more

May 17

SI-BONE, Inc. Announces Publication of Second Multicenter Randomized Controlled Trial of the iFuse Implant System vs. Conservative Care in European Spine Journal

SI-BONE, Inc. Announces Publication of Second Multicenter Randomized Controlled Trial of the iFuse Implant System vs. Conservative Care in European Spine Journal
Read more

May 12

Transparency in research: SI-BONE to make clinical trial data accessible via Yale YODA Project

Transparency in research: SI-BONE to make clinical trial data accessible via Yale YODA Project
Read more

May 3

SI-BONE, Inc. Surpasses 20,000 Surgeries With Triangular iFuse Implant System - Expands International Presence to 25 Countries

SI-BONE, Inc. Surpasses 20,000 Surgeries With Triangular iFuse Implant System - Expands International Presence to 25 Countries
Read more

Apr 20

SI-BONE, Inc. Announces Publication of Two-Year Results From a Prospective Multicenter Clinical Trial Showing Long-Term Clinical Benefits from SI Joint Fusion with the iFuse Implant System

SI-BONE, Inc. Announces Publication of Two-Year Results From a Prospective Multicenter Clinical Trial Showing Long-Term Clinical Benefits from SI Joint Fusion with the iFuse Implant System
Read more

Mar 21

Blue Cross Blue Shield of Michigan Announces Positive Coverage Policy for iFuse Implant System® MIS SI Joint Fusion

Blue Cross Blue Shield of Michigan Announces Positive Coverage Policy for iFuse Implant System® MIS SI Joint Fusion
Read more

Feb 12

SI-BONE, Inc. Announces Medicare Administrative Contractor National Government Services, Inc. Establishes Positive Coverage for MIS SI Joint Fusion Effective April 1st, 2016

SI-BONE, Inc. Announces Medicare Administrative Contractor National Government Services, Inc. Establishes Positive Coverage for MIS SI Joint Fusion Effective April 1st, 2016
Read more

Feb 11

SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money

SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money
Read more

Jan 20

SI-BONE, Inc. Announces European Expansion with Formation of SI-BONE UK Ltd and Key Additions to Management Team

SI-BONE, Inc. Announces European Expansion with Formation of SI-BONE UK Ltd and Key Additions to Management Team
Read more

2015
Dec 21

SI-BONE, Inc. Announces Medicare Administrative Contractor CGS Administrators, LLC Establishes Positive Coverage for MIS SI Joint Fusion Effective February 1st, 2016

SI-BONE, Inc. Announces Medicare Administrative Contractor CGS Administrators, LLC Establishes Positive Coverage for MIS SI Joint Fusion Effective February 1st, 2016
Read more

Nov 9

SI-BONE, Inc.® Announces iFuse Implant System® Receives Indication Cleared by the FDA that Includes Improved Pain, Patient Function and Quality of Life at 12-Months

SI-BONE, Inc.® Announces iFuse Implant System® Receives Indication Cleared by the FDA that Includes Improved Pain, Patient Function and Quality of Life at 12-Months
Read more

Nov 2

SI-BONE, Inc.® Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery

SI-BONE, Inc.® Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery
Read more

Sep 1

SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors

SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
Read more

Aug 24

SI-BONE, Inc. Announces Three Significant Clinical Evidence Publications on iFuse Implant System® for MIS SI Joint Fusion

SI-BONE, Inc. Announces Three Significant Clinical Evidence Publications on iFuse Implant System® for MIS SI Joint Fusion
Read more

Jun 1

SI-BONE, Inc. Announces iFuse MIS SI Joint Fusion Gains Support from North American Spine Society (NASS) with Positive Coverage Policy Recommendation

SI-BONE, Inc. Announces iFuse MIS SI Joint Fusion Gains Support from North American Spine Society (NASS) with Positive Coverage Policy Recommendation
Read more

May 26

SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital

SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital
Read more

May 11

SI-BONE, Inc. Announces INSITE RCT Recipient of Leon L. Wiltse Award for Best Overall Paper at the 2015 ISASS Annual Meeting

SI-BONE, Inc. Announces INSITE RCT Recipient of Leon L. Wiltse Award for Best Overall Paper at the 2015 ISASS Annual Meeting
Read more

May 4

SI-BONE, Inc. Announces Medicare Contractor Cahaba to issue positive coverage of MIS SI Joint Fusion

SI-BONE, Inc. Announces Medicare Contractor Cahaba to issue positive coverage of MIS SI Joint Fusion
Read more

Mar 24

SI-BONE, Inc. Adds SI Joint Specific Patent to IP Portfolio

SI-BONE, Inc. Adds SI Joint Specific Patent to IP Portfolio - Total U.S. Issued Patents now 16
Read more

Mar 9

SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants

SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants
Read more

Mar 2

SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone

SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone
Read more

Jan 6

SI-BONE, Inc. to Present at 2015 JP Morgan Annual Healthcare Conference

SI-BONE, Inc. to Present at 2015 JP Morgan Annual Healthcare Conference
Read more

Jan 5

SI-BONE, Inc. Announces Medicare Noridian Reimbursing for MIS SI Joint Fusion

SI-BONE, Inc. Announces Medicare Noridian Reimbursing for MIS SI Joint Fusion
Read more

2014
Dec 8

SI-BONE, Inc. Garners a Gold MarCom Award for the Patient Advocacy Website

SI-BONE, Inc. Garners a Gold MarCom Award for the Patient Advocacy Website
Read more

Nov 5

SI-BONE, Inc. to Host SI Joint Fusion Symposium at NASS at the W Hotel

SI-BONE, Inc. to Host SI Joint Fusion Symposium at NASS at the W Hotel
Read more

Oct 27

SI-BONE, Inc. Announces Publication of 5 year Follow-up data for iFuse Implant System®

SI-BONE, Inc. Announces Publication of 5 year Follow-up data for iFuse Implant System®
Read more

Looking for Answers?

We can help. Tell us what you're looking for below.